Cite
HARVARD Citation
Stellbrink, H. et al. (n.d.). The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single‐tablet regimen in the expanding spectrum of fixed‐dose combination therapy for HIV. HIV medicine. pp. 3-16. [Online].